VERU INC. Lease, Cost
VERU INC. (VERU) reported Lease, Cost of $206.68 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-10
- VERU INC. lease, cost for the quarter ending 2026-06-30 was $206.68K, a 6.42% increase year-over-year.
- VERU INC. lease, cost for the quarter ending 2026-03-31 was $235.11K, a 0.39% decline year-over-year.
- VERU INC. lease, cost for the quarter ending 2025-12-31 was $194.12K, a 2.12% increase year-over-year.
- VERU INC. lease, cost for the quarter ending 2025-09-30 was $194.12K, a 2.12% increase year-over-year.
- VERU INC. lease, cost for fiscal 2025 was $814.45K, a 6.95% increase from fiscal 2024.
- VERU INC. lease, cost for fiscal 2024 was $761.52K, a 34.79% decline from fiscal 2023.
- VERU INC. lease, cost for fiscal 2023 was $1.17M, a 20.82% increase from fiscal 2022.
- VERU INC. lease, cost for fiscal 2022 was $966.54K, a 61.70% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 6 month as first filed | Lease, Cost 9 month | Lease, Cost 9 month as first filed | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $206.68K 10-Q · filed 2026-08-10 | $441.79K derived: sum of 2 quarters · filed 2026-08-10 | $635.91K 10-Q · filed 2026-08-10 | $830.03K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $235.11K 10-Q · filed 2026-05-13 | $429.23K 10-Q · filed 2026-05-13 | $623.35K derived: sum of 3 quarters · filed 2026-05-13 | $817.56K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $194.12K 10-Q · filed 2026-02-11 | $388.24K derived: sum of 2 quarters · filed 2026-02-11 | $582.45K derived: sum of 3 quarters · filed 2026-08-10 | $818.47K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-09-30 | $194.12K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $388.33K derived: sum of 2 quarters · filed 2026-08-10 | $624.36K derived: sum of 3 quarters · filed 2026-08-10 | $814.45K 10-K · filed 2025-12-17 | ||||
| 2025-06-30 | $194.21K 10-Q · filed 2026-08-10 | $430.24K derived: sum of 2 quarters · filed 2026-08-10 | $620.33K 10-Q · filed 2026-08-10 | $810.42K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $236.03K 10-Q · filed 2026-05-13 | $426.12K 10-Q · filed 2026-05-13 | $616.21K derived: sum of 3 quarters · filed 2026-05-13 | $806.30K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $190.09K 10-Q · filed 2026-02-11 | $380.18K derived: sum of 2 quarters · filed 2026-02-11 | $570.27K derived: sum of 3 quarters · filed 2026-02-11 | $762.03K derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-09-30 | $190.09K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $380.18K derived: sum of 2 quarters · filed 2025-12-17 | $571.94K derived: sum of 3 quarters · filed 2025-12-17 | $761.52K 10-K · filed 2025-12-17 | $1.18M 10-K · filed 2024-12-16 | |||
| 2024-06-30 | $190.09K 10-Q · filed 2025-08-12 | $296.16K 10-Q · filed 2024-08-08 | $381.85K derived: sum of 2 quarters · filed 2025-08-12 | $571.43K 10-Q · filed 2025-08-12 | $884.06K 10-Q · filed 2024-08-08 | $867.07K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $191.75K 10-Q · filed 2025-05-08 | $299.94K 10-Q · filed 2024-05-08 | $381.34K 10-Q · filed 2025-05-08 | $587.90K 10-Q · filed 2024-05-08 | $676.98K derived: sum of 3 quarters · filed 2025-05-08 | $954.18K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $189.58K 10-Q · filed 2025-02-13 | $287.96K 10-Q · filed 2024-04-01 | $485.23K derived: sum of 2 quarters · filed 2025-02-13 | $762.42K derived: sum of 3 quarters · filed 2025-02-13 | $1.06M derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-09-30 | $295.65K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-16 | $572.84K derived: sum of 2 quarters · filed 2024-12-16 | $871.00K derived: sum of 3 quarters · filed 2024-12-16 | $1.17M 10-K · filed 2024-12-16 | ||||
| 2023-06-30 | $277.20K 10-Q · filed 2024-08-08 | $575.35K derived: sum of 2 quarters · filed 2024-08-08 | $872.15K 10-Q · filed 2024-08-08 | $1.17M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $298.16K 10-Q · filed 2024-05-08 | $594.96K 10-Q · filed 2024-05-08 | $893.93K derived: sum of 3 quarters · filed 2024-05-08 | $1.21M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $296.80K 10-Q · filed 2024-04-01 | $595.77K derived: sum of 2 quarters · filed 2024-04-01 | $916.58K derived: sum of 3 quarters · filed 2024-04-01 | $1.12M derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-09-30 | $298.97K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | $619.78K derived: sum of 2 quarters · filed 2024-04-01 | $819.05K derived: sum of 3 quarters · filed 2024-04-01 | $966.54K 10-K/A · filed 2024-04-01 | ||||
| 2022-06-30 | $320.81K 10-Q/A · filed 2023-11-15 | $520.08K derived: sum of 2 quarters · filed 2023-11-15 | $667.57K 10-Q/A · filed 2023-11-15 | $853.03K derived: sum of 4 quarters · filed 2023-11-15 | ||||
| 2022-03-31 | $199.27K 10-Q · filed 2023-05-11 | $346.76K 10-Q · filed 2023-05-11 | $532.22K derived: sum of 3 quarters · filed 2023-05-11 | $676.23K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $147.49K 10-Q · filed 2023-02-09 | $332.95K derived: sum of 2 quarters · filed 2023-02-09 | $476.96K derived: sum of 3 quarters · filed 2023-02-09 | $613.09K derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-09-30 | $185.46K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | $329.47K derived: sum of 2 quarters · filed 2022-12-05 | $465.60K derived: sum of 3 quarters · filed 2022-12-05 | $597.74K 10-K · filed 2022-12-05 | ||||
| 2021-06-30 | $144.01K 10-Q · filed 2022-08-11 | $280.14K derived: sum of 2 quarters · filed 2022-08-11 | $412.28K 10-Q · filed 2022-08-11 | $553.87K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $136.13K 10-Q · filed 2022-05-12 | $268.27K 10-Q · filed 2022-05-12 | $409.86K derived: sum of 3 quarters · filed 2022-05-12 | $518.30K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $132.14K 10-Q · filed 2022-02-09 | $273.73K derived: sum of 2 quarters · filed 2022-02-09 | $382.17K derived: sum of 3 quarters · filed 2022-02-09 | $497.52K derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-09-30 | $141.59K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02 | $250.03K derived: sum of 2 quarters · filed 2021-12-02 | $365.38K derived: sum of 3 quarters · filed 2021-12-02 | $492.09K 10-K · filed 2021-12-02 | ||||
| 2020-06-30 | $108.44K 10-Q · filed 2021-08-12 | $223.79K derived: sum of 2 quarters · filed 2021-08-12 | $350.50K 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | $115.35K 10-Q · filed 2021-05-12 | $242.07K 10-Q · filed 2021-05-12 | ||||||
| 2019-12-31 | $126.72K 10-Q · filed 2021-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |